![]() |
LMK235
- 英文名称:LMK235
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11071
- cas:1418033-25-6
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-05-23
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11071 |
用途 | 科研检测 |
英文名称 | LMK235 |
包装规格 | 1MG |
CAS编号 | 1418033-25-6 |
别名 | LMK235 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C15H22N2O4
分子量:294.35
溶剂:DMSO (25 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Potent, selective inhibitor of HDAC4/5
Function / Pharmacology:Potent and selective inhibitor of HDAC4 (IC50 = 11.9 nM) and HDAC5 (IC50 = 4.2 nM).1 Cytotoxic against human ovarian cancer cell lines A2780 and A2780 CisR (IC50’s = 0.49 μM and 0.32 μM respectively). It displayed synergistic effects with cisplatin and restored sensitivity in platinum-resistant cell lines.1,2 LMK235 induced apoptosis in pancreatic neuroendocrine tumor cell lines BON-1 and QGP-13 and in multiple myeloma cells4. It also induced autophagy and cell death via SCNN1A downregulation in glioblastoma cells.5 LMK235 reduced hypertension in mouse and rat models via inhibition of vascular constriction and vessel hypertrophy.6 LMK235 significantly increased neurite outgrowth via increased BMP-Smad-dependent transcription in SH-SY5Y cells and exerted neuroprotective effects against neurodegeneration induced by MPP+ suggesting possible therapeutic potential in treating Parkinson’s disease.7
分子式:C15H22N2O4
分子量:294.35
溶剂:DMSO (25 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Potent, selective inhibitor of HDAC4/5
Function / Pharmacology:Potent and selective inhibitor of HDAC4 (IC50 = 11.9 nM) and HDAC5 (IC50 = 4.2 nM).1 Cytotoxic against human ovarian cancer cell lines A2780 and A2780 CisR (IC50’s = 0.49 μM and 0.32 μM respectively). It displayed synergistic effects with cisplatin and restored sensitivity in platinum-resistant cell lines.1,2 LMK235 induced apoptosis in pancreatic neuroendocrine tumor cell lines BON-1 and QGP-13 and in multiple myeloma cells4. It also induced autophagy and cell death via SCNN1A downregulation in glioblastoma cells.5 LMK235 reduced hypertension in mouse and rat models via inhibition of vascular constriction and vessel hypertrophy.6 LMK235 significantly increased neurite outgrowth via increased BMP-Smad-dependent transcription in SH-SY5Y cells and exerted neuroprotective effects against neurodegeneration induced by MPP+ suggesting possible therapeutic potential in treating Parkinson’s disease.7